Pheochromocytoma. A case report
Keywords:
Feocromocitoma. Adrenalectomía. Catecolaminas. Paraganglioma. Malignidad.Abstract
We present the case of a 34 year-old male, who was diagnosed with a malign pheochromocytoma and who was treated with left laparascopic suprarenalectomy. This is a neoplasia of the chromoffin cells with a prevalence of two cases per million inhabitants, which generally causes the typical symptoms of episodic freeing of catecholamines. We describe the case’s form of presentation, which began with successive episodes of intense abdominal pain on the left side. In the abdominal pelvic ultrasound and abdominal CT, a mass of 6.5 cm diameter was objectified, dependent on the left suprarenal gland. High levels of metanefrines and catecholamines were evident in the urine. A total left laparoscopic adrenalectomy was carried out. The pathological anatomy showed malign pheochromocytoma.Downloads
References
1. PETRINA ME, CALDERÓN DM, MENÉNDEZ EL. Feocromocitoma y paraganglioma. An Sist Sanit Navar 1998; 21: 31-46.
https://doi.org/10.23938/ASSN.0650
2. BRAVO EL. Evolving concepts in the pathophysiology, diagnosis and treatment of Pheochromocytoma. Endocr Rev 1994; 15: 356-368.
https://doi.org/10.1210/edrv-15-3-356
3. PLOUIN PF, CHATELLIER G, FOFOL I, CORVOL P. Tumor recurrence and hypertension persistence after successful Pheochromocytoma operation. Hypertension 1997; 29: 1133-1139.
https://doi.org/10.1161/01.HYP.29.5.1133
4. ERICKSON D, KUDVA YC, EBERSOLD MJ, THOMPSON GB, GRANT A, CLIVE S et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001; 86: 5210-5216.
https://doi.org/10.1210/jcem.86.11.8034
5. OLEAGA A, GOÑI F. Feocromocitoma: actualización diagnóstica y terapéutica. Endocrinol Nutr 2008; 55: 202-216.
https://doi.org/10.1016/S1575-0922(08)70669-7
6. MANTERO F, TERZOLO M, ARNALDI G, OSELLA G, MASINI AM, ALI A et al. A survey on adrenal incidentaloma in Italy. Study group in adrenal tumours of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85: 637-644.
https://doi.org/10.1210/jc.85.2.637
7. NEUMANN HP, BAUSCH B, MCWHINNEY SR, BENDER BU, GIMM O, FRANKE G et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459-1466.
https://doi.org/10.1056/NEJMoa020152
8. MOTTA-RAMÍREZ GA, REMER EM, HERTS BR GILL IS, HAMRAHIAN AH. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol 2005; 185: 684-688.
https://doi.org/10.2214/ajr.185.3.01850684
9. LENDERS JW, PACAK K, WALTER MM, LINEHAN WM, MANNELLI M, FRIBERG P et al. Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 2002; 287: 1427-1434.
https://doi.org/10.1001/jama.287.11.1427
10. BRAVO EL, TAGLE R. Pheochromocytomas: State of the art and future prospects. Endocr Rev 2003; 24: 539-553.
https://doi.org/10.1210/er.2002-0013
11. WALTHER MM, KEISER HR, LINEHAN WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 1999; 17: 35-39.
https://doi.org/10.1007/s003450050102
12. BRAVO EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994; 15: 356-368.
https://doi.org/10.1210/edrv-15-3-356
13. KEBEBEW E, SIPERSTEIN AE, CLARK OH, DUH QY. Results of laparoscopic adrenalectomy for suspected and unsuspectedmalignant adrenal neoplasms. Arch Surg 2002; 137: 948-951.
https://doi.org/10.1001/archsurg.137.8.948
14. BJØRN E, AIRAZAT MK, TOM M, PER F, TØNNESSEN TI, FOSSE E. Laparoscopic and open surgery for pheochromocytoma. BMC Surgery 2001; 1: 2.
https://doi.org/10.1186/1471-2482-1-2
15. TSURU N, USHIYAMA T, SUZUKI K. Laparoscopic adrenalectomy for primary and secondary adrenal tumours. J Endourology 2005; 19: 702-708.
https://doi.org/10.1089/end.2005.19.702
16. LIAO CH, CHUEH SC, LAI MK, HSIAO PJ, CHEN J. La paroscopic adrenalectomy for potentially malignant adrenal tumours greater than 5 cm. J Clin Endocrinol Metab 2006; 91: 3080-3083.
https://doi.org/10.1210/jc.2005-2420
17. TANAKA S, ITO T, TOMODA J, HIGASHI T, YAMADA G, TSUJI T. Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion. Intern Med 1993; 32: 789-794.
https://doi.org/10.2169/internalmedicine.32.789
18. JIMÉNEZ C, CABANILLAS M, SANTARPIA L, JONASCH E, KYLE K, LANO E et al. Use of the tyrosine kinase inhibitor suitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pPheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab 2009; 94: 386-391.
https://doi.org/10.1210/jc.2008-1972
19. HARARI A, INABNET III W. Malignant pheocromocytoma: a review. Am J Surg 2011; 201: 700-708.
https://doi.org/10.1016/j.amjsurg.2010.04.012
20. SCHOLZ T, SCHULZ C, KLOSE S, LEHNERT H. Diagnostic management of benign and malignant pheochromocytoma. Exp Clin Endocrinol Diabetes 2007; 115: 155-159.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
